Log in to save to my catalogue

Differential expression of biomarkers in saliva related to SARS-CoV-2 infection in patients with mil...

Differential expression of biomarkers in saliva related to SARS-CoV-2 infection in patients with mil...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_83f485388b3e426b91eda73e161450c9

Differential expression of biomarkers in saliva related to SARS-CoV-2 infection in patients with mild, moderate and severe COVID-19

About this item

Full title

Differential expression of biomarkers in saliva related to SARS-CoV-2 infection in patients with mild, moderate and severe COVID-19

Publisher

London: BioMed Central Ltd

Journal title

BMC infectious diseases, 2023-09, Vol.23 (1), p.1-602, Article 602

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Severe COVID-19 is a disease characterized by profound dysregulation of the innate immune system. There is a need to identify highly reliable prognostic biomarkers that can be rapidly assessed in body fluids for early identification of patients at higher risk for hospitalization and/or death. This study aimed to assess whether differential gene exp...

Alternative Titles

Full title

Differential expression of biomarkers in saliva related to SARS-CoV-2 infection in patients with mild, moderate and severe COVID-19

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_83f485388b3e426b91eda73e161450c9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_83f485388b3e426b91eda73e161450c9

Other Identifiers

ISSN

1471-2334

E-ISSN

1471-2334

DOI

10.1186/s12879-023-08573-6

How to access this item